Reproductive and developmental toxicity of Cryptolepis sanguinolenta in mice

Research Journal of Pharmacology

Volumn 4, Issue 1, 2010, Pages 9-14

  Ansah, Charles ^a   Mensah, Kwesi Boadu ^a   Woode, Eric ^a   Duwiejua, Mahama ^a  

^a KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

Author keywords

Cryptolepis sanguinolenta; Fertility; Foetal development; Genotoxicity; Mortality; Reproduction

Indexed keywords

CRYPTOLEPIS SANGUINOLENTA EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BREEDING; CONTROLLED STUDY; CRYPTOLEPIS; CRYPTOLEPIS SANGUINOLENTA; CYTOTOXICITY; DRUG EFFECT; FEMALE; FEMALE FERTILITY; FETUS; FETUS DEVELOPMENT; GENOTOXICITY; GESTATION PERIOD; GROWTH INHIBITION; INTRAUTERINE GROWTH RETARDATION; LD 50; LETHAL DOSE; MALE; MOUSE; NEWBORN; NONHUMAN; ORGANOGENESIS; PLANT ROOT; PREGNANCY DISORDER; REPRODUCTIVE TOXICITY;

EID: 77953460677     PISSN: 18159362     EISSN: None     Source Type: Journal    
DOI: 10.3923/rjpharm.2010.9.14     Document Type: Article

References (33)

1. Ansah, C. and N.J. Gooderham, 2002. The popular herbal antimalarial, extract of Cryptolepis sanguinolenta, is potently cytotoxic. Toxicol. Sci., 70: 245-251.
2. Ansah, C, A. Khan and N.J. Gooderham, 2005. In vitro genotoxicity of the West African anti-malarial herbal Cryptolepis sanguinolenta and its major alkaloid cryptolepine. Toxicology, 208: 141-147.
3. Bamgbose, S.O.A. and B.K. Naomesi, 1981. Studies on cryptolepine II: Inhibition of carrageenan induced oedema by cryptolepine. Planta Med., 41: 392-396.
4. Bonjean, K., M.C. De Pauw-Gillet, M.C. Defresne, P. Colson and C. Houssier et al, 1999. The DNA intercalating alkaloid cryptolepine interferes with topoisomerase II and inhibits primarily DNA synthesis in Bl 6 melanoma cells. Biochemistry, 37: 5136-5146.
5. Bradley, L. and S.A. Doggrell, 1985. Modification by desipramine of the effects of 1-adrenoceptor antagonists on the contractile responses of the trisected rat vas deferens. Gen. Pharmacol., 16: 475-482.
6. Cardonick, E. and A. Iacobucci, 2004. Use of chemotherapy during human pregnancy. Lancet Oncol, 5: 283-291.
7. Casarett, L.J. and J. Doull, 1986. Casarett andDoullâ-™s Toxicology: The Basic Science of Poisons. 3rd Edn., Macmillan, New York, USA.
8. Dassonneville, L., K. Bonjean, De M.C. Pauw-Gillet, P. Colson and C. Houssier et al., 1999. Stimulation of topoisomerase II-mediated DNA cleavage by three DNA-intercalating plant alkaloids: Cryptolepine, matadine and serpentine. Biochemistry, 38: 7719-7726.
9. Doggrell, S.A., 1981. Prazosin selectively inhibits the responses to field stimulation in the rat vas deferens. Eur. J. Pharmacol., 71: 447-453.
10. Dwuma-Badu, D., J.S. Ayim, N.I. Fiagbe, J.E. Knapp, P.L. Schiff andD.J. Slatkin, 1978. Constituents of West African medicinal plants XX: Quindoline from Cryptolepis sanguinolenta. J. Pharm. Sci., 67: 433-444.
11. Fabro, S., J.A. MclachlanandN.M. Dames, 1984. Chemical exposure of embryos during the preimplantation stages of pregnancy: Mortality rate and intrauterine development. Am. J. Obstet. Gynecol, 148: 929-938.
12. Green, S., A. Auletta, J. Fabricant, R. Kapp, M. Manandhar, C.J. Sheu, J. Springer and B. Whitfield, 1985. Current status of bioassays in genetic toxicology-the dominant lethal assay: A report of the U.S. environmental protection agency gene-tox program. Mutat. Res., 154: 49-67.
13. Homonnai, Z.T., M. Shilon and G.F. Paz, 1984. Phenoxybenzamine: An effective male contraceptive pill. Contraception, 29: 479-791.
14. Klaassen, CD., 1996. Casarett and Doull's Toxicology: The Basic Science of Poisons. 5th Edn., McGraw Hill, New York, ISBN: 0071054766.
15. Leslie, K.K., C. Koil and W.F. Rayburn, 2005. Chemotherapeutic drugs in pregnancy. Obstet. Gynecol. Clin North Am., 32: 627-640.
16. Lisgarten, J.N., M. Coll, J. Portugal, C.W. Wright and J. Aymami, 2002. The antimalarial and cytotoxic drug cryptolepine intercalates into DNA at cytosinecytosine sites. Nat. Struct. Biol, 9: 57-60.
17. Meistrich, M.L., 1989. Evaluation of reproductive toxicity by testicular sperm head counts. J. Am. Coll. Tox., 8: 551-567.
18. Noamesi, B.K. and S.O.A. Bamgbose, 1980. The a-adrenoceptor blocking properties of cryptolepine on the rat isolated vas deferens: Studies on cryptolepine. Parti. Planta Med., 39: 51-56.
19. Norgard, B., L. Pedersen, K. Fonoger, S.N. Rasmussen andH.T. Sorensen, 2003. Azathioprine, mercaptopurine and birth outcome: A population-based cohort study. Aliment Pharmacol. Ther., 17: 827-834.
20. Olajide, O.A., A.M. Ajayi and C.W. Wright, 2009. Anti-inflammatory properties of cryptolepine. Phytother, 23: 1421-1425.
21. Ratnasooriya, W.D. and R.M. Wadsworth, 1994. Tamsulosin, a selective alpha 1-adrenoceptor antagonist, inhibits fertility of male rats. Andrologia, 26: 107-110.
22. Ratnasooriya, W.D., 1984. Effect of atropine on fertility of female rat and sperm motility. Indian J. Exp. Biol, 22: 463-466.
23. Rauwald, H.W., M. Kober, E. Mutschler and G. Lambrecht, 1992. Cryptolepis sanguinolenta: Antimuscarinic properties of Cryptolepine and the alkaloid fraction at Ml, M2 and M3 Receptors. Planta Med., 58: 486-488.
24. Russell, L.B. and M.D. Shelby, 1985. Test for heritable genetic damage and for the evidence of gonadal exposure in mammals. MutatRes., 154: 69-84.
25. Sato, T., Y. Ban, M. Uchida, E. Gondo and M. Yamamoto et al., 2005. Atropine-induced inhibition of sperm and semen transport impairs fertility in male rats. J. Toxicol. Sci.,30: 207-212.
26. Shelby, M.D., 1994. Human germ cell mutagenesis. Environ. Mol. Mutagen, 23: 30-34.
27. Skomsvoll, J.F., R.E.K.H. Svean, S.K. Asmund, V.D.V. R. Tarjei and O. Momka, 2005. Reversible infertility from non steroidal antiinflammatory drugs. Tidssk. DenNor. Laegeforen, 125: 1476-1478.
28. Snow, M.H.L. and P.P.L. Tarn, 1979. Is compensatory growth a complicating factor in mouse teratology?. Nature, 279: 555-557.
29. Sofowora, A., 1982. Medicinal Plants and Traditional Medicine in Africa. 1st Edn. John Wiley and Sons, Chichester, New York.
30. Solomon, H.M., P.J. Wire, D.L. Ippolito and T.V. Toscano, 1997. Effect of prazosin on sperm transport in male rats. Reprod. Toxicol., 11: 627-631.
31. Wilson, J.G., 1973. Environment and Birth Defects. 1 st Edn., Academic Press, New York, pp: 233-272.
32. Zanagnolo, V., A.M. Dharmarajan, K. Endo and E.E. Wallach, 1996. Effects of acetylsalicylic acid (aspirin) and naproxen sodium (naproxen) on ovulation, prostaglandin and progesterone production in the rabbit. Fertil. Stenl, 65: 1036-1043.
33. Zemlickis, D., M. Lishner, P. Degendorfer, T. Panzarella, S.B. Sutcliffe and G. Koren, 1992. Fetal outcome after in utero exposure to cancer chemotherapy. Arch. Int. Med., 152: 573-576.